Kestra Medical Technologies Ltd. (KMTS)
25.19
-0.54
(-2.10%)
USD |
NASDAQ |
Sep 03, 16:00
25.19
0.00 (0.00%)
After-Hours: 20:00
Kestra Medical Technologies Research and Development Expense (TTM) : 19.48M for April 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| April 30, 2026 | 19.48M |
| January 31, 2026 | 19.24M |
| October 31, 2025 | 17.62M |
| July 31, 2025 | 16.25M |
| April 30, 2025 | 15.65M |
| Date | Value |
|---|---|
| January 31, 2025 | 14.09M |
| October 31, 2024 | 14.47M |
| July 31, 2024 | 15.16M |
| April 30, 2024 | 15.49M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Rockwell Medical, Inc. | -- |
| Accuray, Inc. | 37.80M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 60.33M |
| ResMed, Inc. | 378.28M |